Interleukin-2 receptor antibody vs ATG for induction immunosuppression after liver transplantation: initial results of a prospective randomized trial

Transplant Proc. 1995 Feb;27(1):1140-1.

Authors

H P Lemmens¹, J M Langrehr, W O Bechstein, G Blumhardt, H Keck, R Lüsebrink, M Knoop, R Lohmann, S Tullius, H Lobeck, et al.

Affiliation

¹ Department of Surgery, Virchow Clinic, Free University, Berlin, Germany.

PMID: 7878826

No abstract available

Publication types

Clinical Trial
Comparative Study
Randomized Controlled Trial

MeSH terms

Adolescent
Adult
Aged
Antibodies, Monoclonal / adverse effects
Antibodies, Monoclonal / therapeutic use*
Antilymphocyte Serum / adverse effects
Antilymphocyte Serum / therapeutic use*
Female
Graft Rejection / epidemiology
Humans
Immunosuppression Therapy / methods
Liver Transplantation / immunology*
Liver Transplantation / mortality
Male
Middle Aged
Postoperative Complications / epidemiology
Prospective Studies
Receptors, Interleukin-2 / immunology*
Survival Rate

Substances

Antibodies, Monoclonal
Antilymphocyte Serum
Receptors, Interleukin-2
inolimomab